# POSITRON CORP: Form D filings

POSITRON CORP, a biotechnology company in Fishers, IN, filed 2 Form D notices with the SEC in 2012. The latest, on November 13, 2012, reports $1.3 million sold of a $5 million offering to 20 investors.

Find out what POSITRON CORP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20POSITRON%20CORP%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=POSITRON%20CORP&page=%2Fdata%2Fform-d%2Fcompany%2Fpositron-corp-844985)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20POSITRON%20CORP%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=POSITRON%20CORP&page=%2Fdata%2Fform-d%2Fcompany%2Fpositron-corp-844985)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Indiana](https://specstream.ai/data/form-d/state/indiana): 436 rows, by operating companies, filed since November 1, 2024, $21.80, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/indiana
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 9715 KINCAID BOULEVARD, SUITE 1000, Fishers, IN, 46038
- Phone: (317) 576-0183
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Texas
- Revenue range: $5,000,001 - $25,000,000
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 844985

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Nov 13, 2012 | New notice | $5,000,000 | $1,300,000 | $3,700,000 | 20 | Apr 20, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/844985/000114420412061193/0001144204-12-061193-index.htm) |
| Nov 13, 2012 | New notice | $3,000,000 | $1,500,000 | $1,500,000 | 20 | Mar 1, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/844985/000114420412061191/0001144204-12-061191-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Patrick J. Rooney | Executive Officer, Director |  |
| Timothy M. Gabel | Executive Officer |  |
| Sachio N. Okamura | Director |  |
| Scott C. Stiffler | Executive Officer |  |
| Corey N. Conn | Executive Officer, Director |  |
| Anthony C. Nicholls | Director |  |
| Joseph G. Oliverio | Executive Officer, Director |  |

## Other biotechnology companies in Indiana that filed recently

- [PAHTIA TECHNOLOGIES INC](https://specstream.ai/data/form-d/company/pahtia-technologies-inc-2123730) $25,000 · Sep 17, 2026

[Every Form D from the week of Nov 12, 2012](https://specstream.ai/data/form-d/week/2012-11-12) · [All recent filings in Indiana](https://specstream.ai/data/form-d/state/indiana) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what POSITRON CORP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).
